Trials / Unknown
UnknownNCT04506476
Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer
Randomisierte Studie Zum Nutzen Des Fitnesstracker Basierten Aktivitätstrainings während Einer Adjuvanten Bestrahlung Des Mammakarzinoms (OnkoFit I)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 201 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized three-arm trial will test the benefit in terms of cancer related fatigue of an activity tracker based exercise training during adjuvant radiotherapy in breast cancer patients.
Detailed description
This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an activity tracker based exercise program in breast cancer patients on the fatigue syndrome during adjuvant radiotherapy. Quality of Life and the intensity of fatigue will be documented with the fatigue subscale of the FACIT Questionnaire three months after adjuvant radiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fitness tracker based activity training for Arm A and B. Booklet "physical training, exercise and cancer" and an introduction about physical activity during cancer therapy for Arm A, B, C | Patients receive a fitness tracker, a booklet "Physical training, exercise and cancer" and an in-person briefing about physical activity during cancer therapy. With offered guidelines for the daily step counts patients should improve their physical activity during radiotherapy of breast cancer. A weekly feedback and a new goal for the next week will be provided until the individual patient reaches a daily activity of 6000 steps. The setting will be to maintain to this daily activity of 6000 steps during radiotherapy. |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2024-08-01
- Completion
- 2025-08-01
- First posted
- 2020-08-10
- Last updated
- 2020-08-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04506476. Inclusion in this directory is not an endorsement.